T. Rowe Price Investment Management »

Sarepta Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $230M 1.9M 121.22

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Fortive Corp Comm Stk (FTV)
Ingersoll Rand Comm Stk (IR)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOGL)
Amazon Comm Stk (AMZN)
Yum Brands Comm Stk (YUM)
Microchip Technology Comm Stk (MCHP)
Intercontinental Exchange In Comm Stk (ICE)
Apple Comm Stk (AAPL)
Becton Dickinson & Co Comm Stk (BDX)
Hologic Comm Stk (HOLX)
Avantor Comm Stk (AVTR)
Hilton Worldwide Hldgs Comm Stk (HLT)
Revvity Comm Stk (RVTY)

View all positions for T. Rowe Price Investment Management

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics